Singapore markets close in 2 hours 43 minutes
Straits Times Index
3,308.03 +4.84 (+0.15%) Nikkei
38,768.13 +532.06 (+1.39%) Hang Seng
18,512.18 -66.12 (-0.36%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,513.27 -863.71 (-1.34%) CMC Crypto 200
1,366.26 +1.13 (+0.08%)
The Oncology Institute, Inc. (TOI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 69.51M |
| Enterprise value | 106.33M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.21 |
| Price/book (mrq) | 1.22 |
| Enterprise value/revenue | 0.33 |
| Enterprise value/EBITDA | -1.51 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.69 |
| 52-week change 3 | 122.92% |
| S&P500 52-week change 3 | 24.49% |
| 52-week high 3 | 2.6550 |
| 52-week low 3 | 0.3300 |
| 50-day moving average 3 | 1.4833 |
| 200-day moving average 3 | 1.5733 |
Share statistics
| Avg vol (3-month) 3 | 116.33k |
| Avg vol (10-day) 3 | 99.05k |
| Shares outstanding 5 | 74.31M |
| Implied shares outstanding 6 | 74.31M |
| Float 8 | 36.19M |
| % held by insiders 1 | 19.71% |
| % held by institutions 1 | 57.59% |
| Shares short (15 Apr 2024) 4 | 251.95k |
| Short ratio (15 Apr 2024) 4 | 1.71 |
| Short % of float (15 Apr 2024) 4 | 0.52% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.34% |
| Shares short (prior month 15 Mar 2024) 4 | 234.26k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -25.62% |
| Operating margin (ttm) | -17.95% |
Management effectiveness
| Return on assets (ttm) | -15.97% |
| Return on equity (ttm) | -92.19% |
Income statement
| Revenue (ttm) | 324.24M |
| Revenue per share (ttm) | 4.40 |
| Quarterly revenue growth (yoy) | 20.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -54.28M |
| Net income avi to common (ttm) | -67.88M |
| Diluted EPS (ttm) | -0.9200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 82.86M |
| Total cash per share (mrq) | 1.12 |
| Total debt (mrq) | 119.67M |
| Total debt/equity (mrq) | 209.86% |
| Current ratio (mrq) | 4.12 |
| Book value per share (mrq) | 0.77 |
Cash flow statement
| Operating cash flow (ttm) | -36.31M |
| Levered free cash flow (ttm) | -16.59M |
© 2024 Yahoo. All rights reserved.